Real‐World Safety and Effectiveness of <scp>JAK</scp> Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the <scp>EUSTAR</scp> Cohort

Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, Unknown

Open source

DOI
10.1002/acr.80100
Published
2026-07-02
Container
Arthritis Care &amp; Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acr.80100,
  title = {Real‐World Safety and Effectiveness of
                    <scp>JAK</scp>
                    Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the
                    <scp>EUSTAR</scp>
                    Cohort},
  author = {Stefano Di Donato and Marie‐Elise Truchetet and Marco Minerba and Oliver Distler and Juan José Alegre Sancho and Yolanda Braun‐Moscovici and Christina Bergmann and Petros Sfikakis and Jeska K. de Vries‐Bouwstra and Murray Baron and Silvia Bellando‐Randone and Lorenzo Dagna and Christopher P. Denton and Madelon C. Vonk and Vanessa Smith and Ivan Castellvi and Gabriela Riemekasten and Andra Balanescu and Masataka Kuwana and Maria De Santis and Kamal Solanki and Anastas Batalov and Vahan Mukuchyan and Marco Matucci‐Cerinic and Yannick Allanore and Francesco Del Galdo and Michael Hughes and Unknown},
  year = {2026},
  journal = {Arthritis Care \&amp; Research},
  doi = {10.1002/acr.80100},
  url = {https://doi.org/10.1002/acr.80100}
}

RIS

TY  - JOUR
TI  - Real‐World Safety and Effectiveness of
                    <scp>JAK</scp>
                    Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the
                    <scp>EUSTAR</scp>
                    Cohort
AU  - Stefano Di Donato
AU  - Marie‐Elise Truchetet
AU  - Marco Minerba
AU  - Oliver Distler
AU  - Juan José Alegre Sancho
AU  - Yolanda Braun‐Moscovici
AU  - Christina Bergmann
AU  - Petros Sfikakis
AU  - Jeska K. de Vries‐Bouwstra
AU  - Murray Baron
AU  - Silvia Bellando‐Randone
AU  - Lorenzo Dagna
AU  - Christopher P. Denton
AU  - Madelon C. Vonk
AU  - Vanessa Smith
AU  - Ivan Castellvi
AU  - Gabriela Riemekasten
AU  - Andra Balanescu
AU  - Masataka Kuwana
AU  - Maria De Santis
AU  - Kamal Solanki
AU  - Anastas Batalov
AU  - Vahan Mukuchyan
AU  - Marco Matucci‐Cerinic
AU  - Yannick Allanore
AU  - Francesco Del Galdo
AU  - Michael Hughes
AU  - Unknown
PY  - 2026
JO  - Arthritis Care &amp; Research
DO  - 10.1002/acr.80100
UR  - https://doi.org/10.1002/acr.80100
ER  - 

APA

Donato, S. D., Truchetet, M., Minerba, M., Distler, O., Sancho, J. J. A., Braun‐Moscovici, Y., Bergmann, C., Sfikakis, P., Vries‐Bouwstra, J. K. D., Baron, M., Bellando‐Randone, S., Dagna, L., Denton, C. P., Vonk, M. C., Smith, V., Castellvi, I., Riemekasten, G., Balanescu, A., Kuwana, M., Santis, M. D., Solanki, K., Batalov, A., Mukuchyan, V., Matucci‐Cerinic, M., Allanore, Y., Galdo, F. D., Hughes, M., & Unknown (2026). Real‐World Safety and Effectiveness of <scp>JAK</scp> Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the <scp>EUSTAR</scp> Cohort. Arthritis Care &amp; Research. https://doi.org/10.1002/acr.80100

Source records